192 related articles for article (PubMed ID: 12685917)
1. Dopaminergic deficit and the role of amisulpride in the treatment of mood disorders.
Montgomery SA
Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S9-15; discussion S16-7. PubMed ID: 12685917
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic deficit and the role of amisulpride in the treatment of schizophrenia.
Kasper S
Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S19-26. PubMed ID: 12685918
[TBL] [Abstract][Full Text] [Related]
3. Amisulpride versus amineptine and placebo for the treatment of dysthymia.
Boyer P; Lecrubier Y; Stalla-Bourdillon A; Fleurot O
Neuropsychobiology; 1999; 39(1):25-32. PubMed ID: 9892856
[TBL] [Abstract][Full Text] [Related]
4. The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophrenia.
Pani L; Gessa GL
Mol Psychiatry; 2002; 7(3):247-53. PubMed ID: 11920152
[TBL] [Abstract][Full Text] [Related]
5. Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group study.
Amore M; Jori MC;
Int Clin Psychopharmacol; 2001 Nov; 16(6):317-24. PubMed ID: 11712619
[TBL] [Abstract][Full Text] [Related]
6. Focus on amisulpride.
Green B
Curr Med Res Opin; 2002; 18(3):113-7. PubMed ID: 12094819
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials.
Levkovitz Y; Tedeschini E; Papakostas GI
J Clin Psychiatry; 2011 Apr; 72(4):509-14. PubMed ID: 21527126
[TBL] [Abstract][Full Text] [Related]
8. Amisulpride versus imipramine and placebo in dysthymia and major depression. Amisulpride Study Group.
Lecrubier Y; Boyer P; Turjanski S; Rein W
J Affect Disord; 1997 Apr; 43(2):95-103. PubMed ID: 9165379
[TBL] [Abstract][Full Text] [Related]
9. Amisulpride in medium-term treatment of dysthymia: a six-month, double-blind safety study versus amitriptyline. AMILONG investigators.
Ravizza L
J Psychopharmacol; 1999; 13(3):248-54. PubMed ID: 10512080
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with amisulpride and antidepressants: clinical observations in case series of elderly patients with psychotic depression.
Politis AM; Papadimitriou GN; Theleritis CG; Psarros C; Soldatos CR
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1227-30. PubMed ID: 18442877
[TBL] [Abstract][Full Text] [Related]
11. An open-label pilot study to evaluate the efficacy of sildenafil citrate in middle-aged men with late-onset dysthymia.
Orr G; Seidman SN; Weiser M; Gershon AA; Dubrov Y; Klein DF
J Nerv Ment Dis; 2008 Jun; 196(6):496-500. PubMed ID: 18552628
[TBL] [Abstract][Full Text] [Related]
12. Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial.
Kim SW; Shin IS; Kim JM; Lee SH; Lee JH; Yoon BH; Yang SJ; Hwang MY; Yoon JS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1504-9. PubMed ID: 17692448
[TBL] [Abstract][Full Text] [Related]
13. Consensus on the use of substituted benzamides in psychiatric patients.
Racagni G; Canonico PL; Ravizza L; Pani L; Amore M
Neuropsychobiology; 2004; 50(2):134-43. PubMed ID: 15292667
[TBL] [Abstract][Full Text] [Related]
14. A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers.
Rosenzweig P; Canal M; Patat A; Bergougnan L; Zieleniuk I; Bianchetti G
Hum Psychopharmacol; 2002 Jan; 17(1):1-13. PubMed ID: 12404702
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, randomised, controlled clinical trial of acetyl-L-carnitine vs. amisulpride in the treatment of dysthymia.
Zanardi R; Smeraldi E
Eur Neuropsychopharmacol; 2006 May; 16(4):281-7. PubMed ID: 16316746
[TBL] [Abstract][Full Text] [Related]
16. Duloxetine in the treatment of major psychiatric and neuropathic disorders.
Müller N; Schennach R; Riedel M; Möller HJ
Expert Rev Neurother; 2008 Apr; 8(4):527-36. PubMed ID: 18416656
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, safety and tolerability of duloxetine 60 mg once daily in major depression.
Cowen PJ; Ogilvie AD; Gama J
Curr Med Res Opin; 2005 Mar; 21(3):345-56. PubMed ID: 15811202
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell cytotoxity and course of illness in depressed mood.
Reynaert C; Janne P; Jacques D; Tordeurs D; Zdanowicz N
Psychiatr Danub; 2010 Nov; 22 Suppl 1():S132-4. PubMed ID: 21057421
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of psychotherapy and combination treatment for chronic depression.
Arnow BA; Constantino MJ
J Clin Psychol; 2003 Aug; 59(8):893-905. PubMed ID: 12858430
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of drug treatments for dysthymia: a systematic review and meta-analysis.
de Lima MS; Hotoph M; Wessely S
Psychol Med; 1999 Nov; 29(6):1273-89. PubMed ID: 10616934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
